Elli Kaplan

Elli Kaplan


Desease Prevention Desease Prevention Desease Prevention


 

Overview

CEO Elli Kaplan is aiming her life’s work at Alzheimer’s and related disorders. “I watched two of my grandparents die ‘alone’ because they could no longer remember their family members who were sitting at their bedsides,” she said. Neurotrack’s test is bolstered by 25 years of neuroscience research. Millions of dollars from foundations and grants have already been poured into the technology, which was developed by researchers at Emery University. The company offers a computer-based cognitive test that can detect an impairment on the Hippocampus, the first structure in the brain to be impacted by Alzheimer’s. The program evaluates patients’ eye movement — and the time spent looking at familiar and new images

Neurotrack

Prevent cognitive decline

Co-Founder and CEO

- Present


Explore

Revision History

Last Update: Aug 16, 2013 12:00 a.m.

Incoming


Tags

COPYRIGHT 2019 IMPACTSPACE. ALL RIGHTS RESERVED.